EXPERIENCE OF SOLCOSERYL USE FOR THE TREATMENT OF VERTEBROGENIC RADICULO-ISHEMIC SYNDROME IN NEUROLOGY PRACTICE IN OUTPATIENT SETTINGS
- Authors: Lebedev IA1, Lebedev I1
-
Affiliations:
- Issue: No 7 (2010)
- Pages: 53-55
- Section: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/278379
- ID: 278379
Cite item
Full Text
Abstract
The present article is concerned with mechanisms of vertebrogenic radiculo-ishemic syndrome (RIS), the experience of the solcoseryl use in comprehensive treatment of 82 patients with RIS compared with a control group of 85 patients with RIS. Among patients receiving solcoseryl, 70% achieved "moderate" and "good" total effect, whereas only 46% of patients in the control group achieved such effect. A similar pattern occurred with respect to individual components of RIS (pain syndrome and sensory-autonomic disorders). It was noted that solcoseryl is drug with high tolerability.
References
- Кузнецов В.Ф. Справочник по вертеброневрологии. Минск. Изд. «Беларусь». 2000. С. 351.
- Попелянский Я.Ю. Ортопедическая неврология (вертеброневрология). М. «МЕДпрессинформ». С. 670.
- Горбачев В.И., Ковалев В.В. Роль оксида азота в патогенезе поражений центральной нервной системы // Журнал неврологии и психиатрии им. С.С. Корсакова. Приложение «Инсульт». 2002. Вып. 7. С. 9-17.
Supplementary files
